Introduction
Developmental delay/intellectual disability (DD/ID) affects approximately 3% of the general population [1] . In China, 11,820,000 people were diagnosed with DD/ID, of whom 954,000 were younger than 6 years of age [2] . Taking care of a patient with DD/ID exerts a substantial financial and emotional burden on his/her family and society. Approximately more than half of DD/ID cases resulted from genetic etiologies, including chromosomal abnormalities, microduplication or microdeletion syndromes, and monogenic disorders [3] . Other etiologies include teratogenic exposures, perinatal asphyxia, infections, etc. [4] .
Submicroscopic chromosomal aberrations (copy number variants, CNVs) play a significant role in the pathogenesis of DD/ID, and the diagnostic yield of chromosomal microarray analysis-(CMA-) detected CNVs associated with these disorders ranges from 12% to 29% [5] [6] [7] [8] . Currently, ® CytoScan ™ 750K Array (Affymetrix, Santa Clara, CA, USA). e procedure was described in our previous publication [13] .
When the fragment size of absence of heterozygosity (AOH) was larger than one-third of the chromosome, analysis software UPD tool_0.2 was used to separate the AOH into uniparental disomy (UPD) or consanguinity by comparison with the parental results.
e detected CNVs were systematically evaluated for clinical significance. e procedure was also described in our previous publication [13] .
Chromosomal Karyotyping.
When a gain and a loss of more than 5 Mb were simultaneously detected at one end of two different chromosomes or at the both ends of a single chromosome in one sample, peripheral blood samples of the normal parents were karyotyped to confirm whether the parents had chromosomal balanced translocations or inversions.
Statistical Analysis.
Statistical analysis was performed by using SPSS software, version 24. e frequency of pCNVs was compared among subgroups of isolated DD/ID, DD/ID with MCA, DD/ID with ASD, and DD/ID with ASD by using the chi-square test. A value of p < 0.05 was considered to indicate statistical significance.
Results

Diagnostic Yields of pCNVs.
We detected 149 pCNVs (including 5 UPDs) in 127 cases (65 males; 62 females), accounting for 20.06% of the series (Table 1 ). ese pCNVs, including 100 deletions and 44 duplications, were highly variable in size, ranging from 223 kb to 102,400 kb (Table 2) .
Fifty-two pCNVs (34.90%, 52/149) were detected in patients with MCA. In the subgroup of MCA, several clinical manifestations were found, including facial dysmorphic features, growth disorders, micro/macrocephaly, cleft palate, ear deformity, abnormal hands or feet, abnormal heart morphology, and abnormal genital system. In addition, 60 pCNVs (18.07%, 60/332) were detected in patients with isolated DD/ID, 3 pCNVs (3.70%, 3/81) were detected in patients with isolated ASD, and 12 pCNVs (16.90%, 12/71) were detected in patients with epilepsy. e proportion of pCNVs detected in patients with MCA was significantly higher than that in patients with isolated DD/ID (p ≤ 0.001 (34.90% vs. 18.07%)) or patients with isolated ASD (p ≤ 0.001 (34.90% vs. 3.70%)) or patients with epilepsy (p � 0.004 (34.90% vs. 16.90%)). e proportion of pCNVs in patients with isolated ASD was significantly lower than that in patients with isolated DD/ID (p ≤ 0.001 (3.70% vs. 18.07%)) or patients with ASD (p � 0.007 (3.70% vs. 16.90%)). Table 3) .
Microdeletion/Microduplication
Most of the microdeletion/microduplication syndromes were de novo (63/77), including 2 patients with AS caused by paternal UPD15 and 3 patients with Russell-Silver syndrome (RSS) caused by maternal UPD7. However, some patients inherited neurocognitive disorder susceptibility loci, including 16p11.2 recurrent microdeletion (1/3) and 16p13.11 recurrent microduplication/microdeletion (2/4) from their normal parents. Two male patients had maternally inherited Xq28 (MECP2) duplication, and 1 male patient had maternally inherited Xp11.22-linked intellectual disability. All 3 cases with 15q11-q13 duplication syndrome were inherited from their normal mothers, in which one also suffered from 16p11.2 recurrent microdeletion inherited from her normal father (Figure 1(a) ).
Submicroscopic Unbalance Rearrangements.
Of the 127 cases with abnormal results, 18 cases were detected with submicroscopic unbalance rearrangements (14.17%), including 10 cases inherited from parental balanced translocations or pericentric inversions (Figure 1(b) ). Fifteen cases had subtelomeric aberrations at the end of two different chromosomes, of which 8 cases were inherited from normal parents with balanced translocations confirmed by karyotyping. ree cases had subtelomeric aberrations at both ends of the same chromosome, of which 2 cases were inherited from normal parents with pericentric inversions confirmed by karyotyping.
Discussion
e establishment of genetic etiological diagnoses for DD/ ID children is usually challenging due to the high frequency of relatively nonspecific symptoms shared by numerous potential syndromes. We identified pCNVs in 20.06% of cases, which was comparable to other reported series [8, [14] [15] [16] [17] . Interestingly, our study revealed some new findings with certain clinical significance.
More Deletions than Duplications in pCNVs.
In our study, the proportion of deletions was extremely higher than duplications in pCNVs. is finding is consistent with the notion of Ruderfer et al. [18] that many duplications present in the human genome are benign, and most phenotypically normal individuals possess a higher number of duplications than deletions. e dosage-sensitive genes have the ability to cause phenotypes [9] . In our study, 32 genes were confirmed with "sufficient evidence for haploinsufficiency" in the pathogenic deletions, while only 2 genes were confirmed with "sufficient evidence for triplosensitivity" in the pathogenic duplications (https://www.clinicalgenome.org/), which influenced the phenotypes of these patients.
us, deletions contributed more pathogenic interpretations than duplications.
Diagnostic Yields Associated with the Phenotypes.
e diagnostic yield of pCNVs (including microdeletion/ microduplication syndromes) in the MCA subgroup was significantly higher than that in the other 3 subgroups, which implied that severe and complex phenotypes, such as dysmorphology or congenital anomalies, tend to have a higher likelihood of identifying a genetic etiology [4] . Case 92 is a 13-year-old female who has mild ID, specifically a learning disability with a cleft palate. CMA revealed a 5242-kb duplication in the 15q11.2q13.1 (15q11-q13 duplication syndrome) inherited from her normal mother and a 748-kb deletion in 16p11.2 (16p11.2 recurrent microdeletion) inherited from her normal father. Evidence suggests that maternally derived 15q11.2q13.1 duplications are more frequently associated with abnormal phenotypes [19] . Weiss et al. [20] reported that the phenotype of 16p11.2 recurrent microdeletion is characterized by DD, ID, and/or ASD. It is rare that one patient suffers from two different microdeletion/microduplication syndromes. We hypothesized that both the duplication and deletion contributed to the phenotype of the patient. e probability of her parents having another baby with one of the pCNVs or for both is extremely as high as 75%. Wolfe et al. [21] identified that 16p11.2 deletions and 15q11.2q13.1 duplications had incomplete penetrance with high frequencies in neurodevelopmental disorders; however, they sometimes can be observed in healthy controls. So, the phenotype of the baby with pCNV(s) could not be confirmed before birth.
In the isolated DD/ID subgroup and DD/ID with epilepsy subgroup, the diagnostic yields of pCNVs were significantly lower than those of the MCA subgroup but significantly higher than those of the isolated ASD subgroup. e more phenotypes the patients had, such as epilepsy, the higher the likelihood of finding a genetic etiology [9] . However, the diagnostic yields of pCNVs between these two subgroups were not statistically significant. Next-generation sequencing (NGS) also contributes to the identification of epilepsy caused by monogenic mutations [22] , which might be omitted by CMA.
e diagnostic yield of pCNVs was significantly lower in the patients with isolated ASD than in the other 3 subgroups, which was consistent with the results of Ho et al. [16] . We assumed that some other genetic etiologies, such as singlegene disorders, may contribute to the pathogenesis of ASD, which requires further investigation. We detected 3 microdeletion/microduplication syndromes in this subgroup, including Smith-Magenis syndrome, Potocki-Lupski syndrome, and 2q37 monosomy, which were reported in the previous studies [23, 24] . us, we believe that the correct genetic diagnosis confirmed by CMA is imperative to medical management and prognostic evaluation of patients with DD/ID.
Assessment of Recurrence Risks.
In our study, microdeletion/microduplication syndromes were detected in 76 patients. As most of the syndromes are de novo (63/77), the recurrence risk of these sporadic syndromes is extremely low. However, the parents of the DD/ID patients with maternally derived 15q11-q13 duplication (Cases 23, 24, and 92) or some parentally derived recurrent CNVs such as 16p11.2 microdeletion (Case 92) or 16p13.11 microduplication/microdeletion (Cases 22 and 86) have a recurrence risk of 50%. In addition, the parents of male patients with maternally derived X-chromosomal aberrations including Xp22.31 deletion, Xq28 duplication, or Xp11.22 duplication have a recurrence risk of 25%. Hence, the CMA results of these parents are more vital to evaluate the recurrence risk in reproduction.
In the 127 cases with pCNVs, 18 cases (14.17%) were identified with submicroscopic subtelomeric aberrations, including 7 patients suffering from microdeletion/microduplication syndromes, which was consistent with the results of Cheng et al. [25] . In the 18 cases, 8 families were confirmed with parental balanced translocations and 2 families were confirmed with pericentric inversions by karyotyping. ese families have an extremely high risk of having another child with submicroscopic subtelomeric aberrations induced DD/ID (10/18). Conventional cytogenetics can only recognize chromosomal rearrangements with a limited resolution of 5∼10 Mb [9] . ere were still 8 cases diagnosed as de novo submicroscopic subtelomeric aberrations by comparing with the karyotypes of their parents. ese parents should be further tested whether they have balanced translocations or pericentric inversions by locus specific FISH probes according to the results of CMA. Fortunately, all the 18 families may possibly have a healthy child if effective genetic counseling was given based on reasonable techniques of prenatal or preimplantational diagnosis.
Limitations of CMA.
Parental study is usually indispensable because it not only helps with the interpretation of the clinical significance of CNVs but also contributes to genetic counseling and the evaluation of recurrence risk of genetic abnormalities [26] . However, even though the results of normal parents were compared with their children, there was still 1.11% VUS in our study. In general, the rate of VUS will decrease as more CMA results are obtained from the normal parents. e establishment of a normal individual CMA database might be helpful to address this issue. CMA has been confirmed as a vital technology to offer extremely higher diagnostic yield compared with chromosomal karyotype analysis in DD/ID. However, the genetic etiology of approximately 80% of patients remains unknown. Development of NGS offers another option for the genetic diagnosis of DD/ID. Currently, with an increased number of pathogenic mutations of genes associated with DD/ID detected by NGS, the diagnostic yield could be further improved by 20∼30% [27, 28] . A combination of CMA and NGS could be a comprehensive strategy, but the cost-effectiveness should be considered.
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